Meyers J, Mitra D, Doan J, Leeflang C. The role of patient selection criteria in identifying ovarian cancer patients in a retrospective database analysis. Poster presented at the 2010 ISPOR 13th Annual European Congress; November 15, 2010. [abstract] Value Health. 2010 Nov; 13(7):A281.
Arana A, Wentworth CE, Rivero E, Plana E, Conde E. Lymphoma among patients with atopic dermatitis treated with topical corticosteroids (TCS) and/or topical calcineurin inhibitors (TCIs). Poster presented at the 26th International Conference on Pharmacoepidemiology; August 2010. Brighton, England. [abstract] Pharmacoepidemiol Drug Saf. 2010 Aug; 19(S1):S12.
Tennis P, Rothman KJ, Bohn R, Tan H, Anthony MS, Zavras A, Calingaert B. Multiple myeloma and IV bisphosphonate are risk factors for osteonecrosis of the jaw. Poster presented at the 26th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 25, 2010. Brighton, United Kingdom. [abstract] Pharmacoepidemiol Drug Saf. 2010 Aug; 19(S1):S313-4.
Huang K, Gutierrez LP, Bulow S, Gallinger S, Castells A, Eagle CJ, Church JM. Clinical outcomes in familial adenomatous polyposis (FAP) patients with a long-term treatment of celecoxib: a matched cohort study. Poster presented at the 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2010. Brighton, United Kingdom. [abstract] Pharmacoepidemiol Drug Saf. 2010 Aug; 19(Suppl 1):S:61.
Gilsenan AW, Andrews EB, Midkiff KD, Ladner A. Charting a new course in long-term safety: the critical role of cancer registries. Poster presented at the 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2010. Brighton, United Kingdom. [abstract] Pharmacoepidemiol Drug Saf. 2010 Aug; 19(Suppl 1):S116.
Colosia AD, Khan SB, Peltz G, Pohl G, Liu E, Kaye JA. Electronic medical records: quality cancer care and cost-effectiveness. Poster presented at the 2010 ISPOR 15th Annual International Meeting; May 26, 2010. [abstract] Value Health. 2010 May; 13(3):A52.